Latest TroVax Stories
Trial Progressing On Track; BETHESDA, Md., Aug.
AUSTIN, Texas, Aug.
ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Refractory Patients LAWRENCEVILLE, N.J., July 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies.
LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Retrospective Study of Roswell Park Patients Documents Safety and Benefit of Complex Immunotherapy Buffalo, NY (PRWEB) May 06, 2014 A retrospective study
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash.
ThermoDox Demonstrates Impressive Response Rate in Refractory Patients LAWRENCEVILLE, N.J., Feb.
WORCESTER, Mass. and TORONTO, Feb.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.